EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Variant Interpretation to Biomarker Translation: Multi‐omics Integration in Inherited Neuromuscular Diseases

Suming Zhang iD, Xiaoling Lang iD, Lunxin Liu iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/9236120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Mutation, online erschienen am 21.07.2026. Verfasst von Suming Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Disease and Birth Defects of Ministry of Education, West China Secon…. Hauptthemen laut MEDLINE: Neuromuscular Diseases, Biomarkers. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic neuromuscular diseases are highly heterogeneous disorders characterized by diagnostic challenges and limited therapeutic options, underscoring an urgent need for precise biomarkers. The rapid advancement of multi‐omics technologies has broadened biomarker discovery from single genomics to multidimensional integrative analyses encompassing transcriptomics, proteomics, and metabolomics. This progression offers opportunities to improve disease diagnosis, subtyping, prognosis assessment, and treatment monitoring. However, translational gaps persist between multi‐omics discoveries and clinically applicable biomarkers. This review systematically examines the current application of multi‐omics biomarkers in genetic neuromuscular diseases. It provides an in‐depth analysis of the multifaceted barriers encountered during the translation process, including technical hurdles, clinical validation complexities, data interpretation challenges, and health system‐level obstacles. Furthermore, the review explores emerging solutions including artificial intelligence‐assisted decision‐making, ethical governance, and policy preparedness. The review aims to offer a framework for constructing a potentially responsible and efficient multi‐omics translation in genetic neuromuscular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromuscular DiseasesBiomarkersHumansMultiomicsProteomicsGenomicsMetabolomicsTranslational Research, Biomedical

Stichwörter der Autor:innen

artificial intelligencebiomarkersclinical translationgenetic neuromuscular diseasesmulti-omics integrationvariant of uncertain significance

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Disease and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China, sc…
  • Office of Operations Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn.
  • Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn.

ORCID-Profile: Suming Zhang, Xiaoling Lang, Lunxin Liu

Zitieren

APA

Zhang, S., Lang, X., & Liu, L. (2026). From Variant Interpretation to Biomarker Translation: Multi‐omics Integration in Inherited Neuromuscular Diseases. Human Mutation, 2026(1). https://doi.org/10.1155/humu/9236120

Vancouver

Zhang S, Lang X, Liu L. From Variant Interpretation to Biomarker Translation: Multi‐omics Integration in Inherited Neuromuscular Diseases. Human Mutation. 2026;2026(1). doi:10.1155/humu/9236120

BibTeX
@article{Zhang2026,
  author = {Zhang, Suming and Lang, Xiaoling and Liu, Lunxin},
  title = {From Variant Interpretation to Biomarker Translation: Multi‐omics Integration in Inherited Neuromuscular Diseases},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/9236120}
}
Kostenlos starten →